Ethical Aspects of Clinical Trials Outsourced by Western Pharmaceutical Companies to the GDR
DOI:
https://doi.org/10.14394/etyka.511Keywords:
Berlin, NRD, Niemcy Zachodnie, Drezno, HamburgAbstract
Between 1983 and 1990, at least 163 Western drugs were tested in the GDR. On the basis of archival documentation, relevant literature, and interviews we examined the clinical trials of five drugs more thoroughly; two of these individual case studies are introduced in this article. In the case of the clinical trials of the synthetic human growth hormone Saizen we found extensive trial and patient documentation, which allows for a detailed analysis of ethical aspects such as parent information and informed patient consent. In the case of the clinical trials of the „abortion pill“ Mifepristone (RU-486) for the World Health Organization we uncovered irregularities with regard to the ethical evaluation. However, taken together, we could not find any serious violation of ethical norms in connection with our cases studies.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Works published in ETYKA are available under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0), which entails acknowledgement of authorship. Under this licence, Authors keep their copyrights and agree that their works can be used again legally for any purpose, including commercial ones, without the need to obtain previous consent of the Author or publisher. The articles can be downloaded, printed, copied and disseminated; under the condition that the authorship is indicated accordingly, together with the place of original publication. The Authors preserve their copyrights to the above-mentioned works without any limitation whatsoever.
